-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q4 2017 to Q4 2023.
- Arrowhead Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending December 31, 2023 was -$118M, a 56% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$154M, a 13% decline from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$136M, a 179% decline from 2021.
- Arrowhead Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $171M.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)